[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.3.44. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Views 469
Citations 0
Editor's Note
October 2013

The Importance of a Name

JAMA Dermatol. 2013;149(10):1245. doi:10.1001/jamadermatol.2013.5483

The article on “Neutrophilic Urticaria With Systemic Inflammation: A Case Series” by Belani et al1 was published because we believed that our readers were unfamiliar with this concept. Additionally, the approach of treating with interleukin 1 antagonists is relatively underappreciated in the dermatologic community. Lipsker et al2 had previously noted this issue under a different nomenclature, neutrophilic urticarial dermatosis.2 While we recognize the concept that both groups are describing the same disease, we believe that the name proposed by Belani et al more accurately reflects the need to consider systemic disease than that proposed previously.

References
1.
Belani  H, Gensler  L, Bajpai  U,  et al.  Neutrophilic urticaria with systemic inflammation: a case series. JAMA Dermatol. 2013;149(4):453-458.PubMedArticle
2.
Kieffer  C, Cribier  B, Lipsker  D.  Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease: report of 9 new cases and review of the literature. Medicine (Baltimore). 2009;88(1):23-31.PubMedArticle
×